A detailed history of Ameliora Wealth Management Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Ameliora Wealth Management Ltd. holds 1,000 shares of ABBV stock, worth $171,730. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,000
Previous 1,700 41.18%
Holding current value
$171,730
Previous $292 Million 32.27%
% of portfolio
0.08%
Previous 0.13%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$163.84 - $199.33 $114,688 - $139,531
-700 Reduced 41.18%
1,000 $197 Million
Q1 2024

Apr 16, 2024

BUY
$159.82 - $182.1 $159,820 - $182,100
1,000 Added 142.86%
1,700 $310 Million
Q4 2023

Jan 10, 2024

SELL
$137.6 - $154.97 $12,659 - $14,257
-92 Reduced 11.62%
700 $108 Million
Q3 2023

Oct 10, 2023

BUY
$133.59 - $154.65 $12,290 - $14,227
92 Added 13.14%
792 $118 Million
Q3 2022

Nov 07, 2022

BUY
$134.21 - $153.93 $93,947 - $107,751
700 New
700 $97,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ameliora Wealth Management Ltd. Portfolio

Follow Ameliora Wealth Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameliora Wealth Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Ameliora Wealth Management Ltd. with notifications on news.